Elsevier

Analytical Biochemistry

Volume 173, Issue 2, September 1988, Pages 463-468
Analytical Biochemistry

Chemical degradation of 3H-labeled substance P in Tris buffer solution

https://doi.org/10.1016/0003-2697(88)90215-1Get rights and content

Abstract

Substance P (SP) is an important neuropeptide that has been implicated in several physiological processes, and it is necessary to devise an analytical procedure to measure endogenous SP with a combination of high sensitivity and maximum molecular specificity. However, the unique chemical nature of SP (polarity, chemical stability, ease of oxidation, peptide bond lability) plays a significant role in its analysis, such as in receptor assays, immunoassays, chromatography, and mass spectrometry. In this study, we evaluated in polypropylene and glass assay tubes the effects on the recovery and stability of tritiated SP ([3H]SP) of several pertinent experimental parameters such as buffer, pH, multiple freeze-thaw cycles, and incubation temperature and time. Bovine serum albumin (BSA) effectively reduced the absorption of [3H]SP to polypropylene and glass tube surfaces. Following multiple (6×) freeze-thaw cycles of solutions in BSA-precoated tubes, the recovery of radioactive [3H]SP remained high (>75%) after the last cycle, whereas recovery was minimal in uncoated or siliconized glass tubes. A high level of radioactivity recovery was maintained for 14 days of storage of [3H]SP in triethylamine formate (TEAF) solution in BSA-precoated tubes at 4 and −20°C, but decreased at 37°C to less than 80% in only 3 h. Following storage in Tris-HCl (pH 7.4) buffer, a combination of HPLC and mass spectrometric analyses revealed that a significant amount of peptide bond cleavage occurred to produce the two peptides ArgProLys (RPK) and ArgProLysProGlnGln (RPKPQQ), with only a small amount of remaining intact SP. That decomposition was not observed in triethylamine formate TEAF (pH 3.14) buffer solutions.

References (15)

  • C. Dass et al.

    Anal. Biochem

    (1987)
  • M. Maruyama

    Brain Res

    (1986)
  • E. Floor et al.

    Anal. Biochem

    (1980)
  • P.W. Mantyh et al.

    Brain Res

    (1984)
  • J.R. Brown et al.

    Trends Neurosci

    (1986)
  • M.E. Hall et al.

    Peptides

    (1983)
  • M.M. Chang et al.

    Nature New Biol

    (1971)
There are more references available in the full text version of this article.

Cited by (10)

  • Considerations for Defining the Intravenous Administration Procedure for Nano-dose Sterile Drug Product in Clinical Studies

    2022, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Therefore, the compatibility and recovery of the drug substance will be established prior to finalizing the clinical and commercial drug product, which ensures that an appropriate dosing kit is selected to deliver the potency, quality and safety of the product for human use. The loss of drug substance to the surfaces of dosing kits is more pronounced for low strength and/or low dose drug products.12 For example, Higa et al., have demonstrated that ultra-low dose substance P, an undecapeptide amide, significantly adsorbed onto untreated polypropylene and glass surfaces but the potency was effectively increased by coating the surfaces with bovine serum albumin (BSA).12

  • Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator

    2018, Journal of Inorganic Biochemistry
    Citation Excerpt :

    The fully optimized labelling reaction was then applied to the synthesis of 99mTc2. For this compound, the second step of the labelling procedure was performed in an Eppendorf Protein LoBind tube and in presence of γ-cyclodextrin (5 mg/mL), otherwise the SP-conjugated ligand and the final complex stick in the vial surface (data not shown) [57]. The RCY was about 72%; a radiochemically pure compound as showed in Scheme 1 D was achieved by RP-HPLC purification from the labelling mixture.

View all citing articles on Scopus
View full text